EZSCAN is a medical device for the early detection of peripheral autonomic neuropathies to identify people at increased risk of diabetes (pre-diabetes included).
Small fiber neuropathy and diabetes Several studies have proven that small fiber neuropathies are common in people with insulin resistance and prediabetes (IGT) [1] [2]. Sudomotor function is known to reflect sympathetic activity and to provide insight into postganglionic autonomic innervation. Its assessment represents a useful tool to evaluate autonomic disorders [3]. Investigation of sudomotor
EZSCAN is widely used around the world as a screening tool. Screening and prevention in pharmacies This pharmacy offers a diabetes prevention programme including the screening of diabetes risk and the follow-up. Pharmacie Saurel, Perpignan (France) Large screening population in Netherlands, more than 10,000 people already tested with EZSCAN EZSCAN and occupational medicine AinoActive is
EZSCAN is a device that can detect the risk of diabetes EZSCAN is a medical device for the early detection of peripheral autonomic neuropathies to identify people at increased risk of diabetes (pre-diabetes included). This is an alternative method of screening to optimize prevention and management of diabetes risk. EZSCAN RESULT SCREEN A risk score
Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12
Website dedicated
to health professionals
I am a health professional
